This article is sponsored by Sandoz, a Novartis division, and global leader in generic pharmaceuticals and biosimilars. When I started working in the health care industry over 25 years ago, I was compelled by a passion to make a difference and improve the lives of those around me. Ultimately, that mission brought me to Sandoz,
Biosimilars have saved patients billions of dollars and are changing the treatment landscape. Here’s how. originally appeared in KevinMD.com.
